EX-10.1
Published on November 16, 2026
Exhibit 10.1
LINE OF CREDIT AGREEMENT AND NOTE
| AGREEMENT DATE | LOAN TERM | LINE
OF CREDIT LIMIT | DRAW EXPIRATION DATE | MATURITY DATE | ||||||
| November 9, 2026 | 36 Months | $ | 300,000.00 | March 31, 2027 | November 9, 2029 | |||||
| LOAN PURPOSE: LINE OF CREDIT FOR WORKING CAPITAL | ||
| BORROWER INFORMATION | LENDER INFORMATION | |
| Inhibitor Therapeutics, Inc. | Hopkins Capital Group, LLC | |
| 3014 West Palmira Ave Suite 302 | 3014 West Palmira Ave Suite 302 | |
| Tampa, FL 33629 | Tampa, FL 33629 | |
LINE OF CREDIT AGREEMENT AND NOTE. This Line of Credit Agreement and Note will be referred to in this document as the “Agreement”.
LENDER. “Lender” means Hopkins Capital Group, LLC, with an address as set forth above, along with his successors and assigns.
BORROWER. “Borrower” means Inhibitor Therapeutics, Inc., a Delaware corporation.
PROMISE TO PAY. For value received, receipt of which is hereby acknowledged, on or before the Maturity Date, the Borrower promises to pay the principal amount of Three Hundred Thousand and 00/100 Dollars ($300,000.00) or such lesser amount as shall have been advanced by Lender, from time to time, to or on behalf of Borrower under this Agreement, and all interest and any other charges, including service charges, to the order of Lender at his office at the address noted above or at such other place as Lender may designate in writing. The Borrower will make all payments in lawful currency of the United States of America.
PAYMENT SCHEDULE. This Agreement will be paid according to the following required payment schedule: Payment of the full then-outstanding Principal balance plus all accrued and unpaid interest shall be made on the Maturity Date or on any Accelerated Maturity Date as defined below. All payments received by the Lender from the Borrower for application to the Line of Credit may be applied to the Borrower’s obligations under the Line of Credit in such order as determined by the Lender.
“Accelerated Maturity Date” shall mean
| i) | The date of sale of all or substantially all of the assets of Borrower; |
| ii) | The date of any change in control of Borrower, whether by sale, merger, or other cause; |
| iii) | The date of entry into a License or other strategic transaction involving the principal developmental asset of Borrower |
NOTE: The Borrower may make payment(s) of all or any portion of the sums advanced by Lender pursuant to this Agreement at any time prior to the Maturity Date, without penalty.
ADVANCES BY LENDER. Advances of principal under this Agreement shall be made as follows, unless a different schedule is agreed to by Lender and Borrower by written agreement:
| a. | Initial Advance: $150,000 within five (5) days of the Agreement Date set forth above; |
| b. | Second Advance: $150,000 on or prior to December 31, 2026. |
Lender, in his sole discretion and subject to provisions related to obligatory advances, may refuse to make advances hereunder during any period(s) this Agreement is in default. All advances made will be charged to a loan account in Borrower’s name on Lender’s books, and the Lender shall debit such account for the amount of each advance made to, and credit to such account the amount of each repayment made by Borrower.
INTEREST RATE. The interest rate on this Agreement will be 4.67% per annum, accrued and payable at Maturity.
LATE PAYMENT CHARGE. If any required payment is more than 10 days late, then at Lender’s option, Lender will assess a late payment charge of 5% of the amount past due.
LINE OF CREDIT TERMS. This is an Obligatory Agreement. The Borrower and Lender agree that the Borrower shall receive the advances upon the schedule set forth above if, at the time of the scheduled advance, none of the following conditions exist.
| ● | Maximum amount on this Agreement is outstanding. | |
| ● | Undersigned has breached any of the terms, provisions, representations, requirements or promises contained in this Agreement or any other agreement noted below. | |
| ● | The Agreement or any other agreement relating thereto is in default. |
| ● | Undersigned makes a request for an advance after the Draw Expiration Date cited above. |
| ● | The Lender has deemed itself insecure or there has been a material adverse change of conditions. |
| ● | The Lender is precluded by law from making the advance. |
RIGHT OF SET OFF. To the extent permitted by law, Borrower agrees that Lender has the right to set off any amount due and payable under this Agreement, whether matured or unmatured, against any amount owing by Lender to Borrower. Such right of setoff may be exercised by Lender against Borrower or against any assignee for the benefit of creditors, receiver, or execution, judgment or attachment creditor of Borrower, or against anyone else claiming through or against Borrower of such assignee for the benefit of creditors, receiver, or execution, judgment or attachment creditor, notwithstanding the fact that such right of setoff has not been exercised by Lender prior to the making, filing or issuance or service upon Lender of, or of notice of, assignment for the benefit of creditors, appointment or application for the appointment of a receiver, or issuance of execution, subpoena or order or warrant.
DEFAULT. Upon the occurrence of any one of the following events (each, an “Event of Default” or “default” or “event of default”), Lender’s obligations, if any, to make any advances will, at Lender’s option, immediately terminate and Lender, at its option, may declare all indebtedness of Borrower to Lender under this Agreement to be immediately due and payable without further notice of any kind notwithstanding anything to the contrary in this Agreement or any other agreement. (a) Borrower’s failure to make any payment on time or in the amount due; (b) any default by Borrower under the terms of this Agreement or any other agreement executed in connection with this Agreement (individually, a “Loan Document” and collectively, the “Loan Documents”); (c) any default by Borrower under the terms of any other loan agreement, security agreement, mortgage or other document in favor of Lender,; (d) the death, dissolution, or termination of existence of Borrower; (e) Borrower is generally not paying Borrower’s debts as such debts become due; (f) the commencement of any proceeding under bankruptcy or insolvency laws by or against Borrower or the appointment of a receiver; (g) any default under the terms of any other indebtedness of Borrower to any other creditor; (h) any writ of attachment, garnishment, execution, tax lien or similar instrument is issued against any collateral securing the loan, if any, or any of Borrower’s property or any judgment is entered against Borrower; (i) any part of Borrower’s business is sold to or merged with any other business, individual, or entity; (j) any representation or warranty made by Borrower to Lender in any of the Loan Documents or any financial statement delivered to Lender proves to have been false in any material respect as of the time when made or given; (k) Lender has deemed itself insecure or there has been a material adverse change of condition of the financial prospects of Borrower or any collateral securing the obligations owing to Lender by Borrower.
GENERAL WAIVERS. To the extent permitted by law, the Borrower severally waives any required notice of presentment, demand, acceleration, intent to accelerate, protest and any other notice and defense due to extensions of time or other indulgence by Lender or to any substitution or release of collateral. No failure or delay on the part of Lender, and no course of dealing between Borrower and Lender, shall operate as a waiver of such power or right, nor shall any single or partial exercise of any power or right preclude other or further exercise thereof or the exercise of any other power or right.
SEVERABILITY. If a court of competent jurisdiction determines any term or provision of this Agreement is invalid or prohibited by applicable law, that term or provision will be ineffective to the extent required. Any term or provision that has been determined to be invalid or prohibited will be severed from the rest of this Agreement without invalidating the remainder of either the affected provision or this Agreement
SURVIVAL. The rights and privileges of the Lender hereunder shall inure to the benefits of its successors and assigns, and this Agreement shall be binding on all heirs, executors, administrators, assigns and successors of Borrower.
ASSIGNABILITY. Lender may assign, pledge or otherwise transfer this Agreement or any of its rights and powers under this Agreement without notice, with all or any of the obligations owing to Lender by Borrower, and in such event the assignee shall have the same rights as if originally named herein in place of Lender. Borrower may not assign this Agreement or any benefit accruing to it hereunder without the express written consent of the Lender.
ORAL AGREEMENTS DISCLAIMER. This Note represents the final agreement between the parties and may not be contradicted by evidence of prior, contemporaneous or subsequent oral agreements of the parties. There are no unwritten oral agreements between the parties.
GOVERNING LAW. This Agreement is governed by the laws of the state of Delaware except to the extent that federal law controls.
HEADING AND GENDER. The headings preceding text in this Agreement are for general convenience in identifying subject matter but have no limiting impact on the text which follows any particular heading. All words used in this Agreement shall be construed to be of such gender or number as the circumstances require.
ATTORNEYS’ FEES AND OTHER COSTS. If legal proceedings are instituted to enforce the terms of this Agreement, Borrower agrees to pay all costs of the Lender in connection therewith, including reasonable attorneys’ fees, to the extent permitted by law.
WAIVER OF JURY TRIAL. All parties to this Agreement hereby waive, to the fullest extent permitted by law, any right to trial by jury with respect to any dispute, whether in contract, tort, or otherwise, arising out of, in connection with, related to, or incidental to the relationship established between them in this Agreement or any other instrument, document, or agreement executed or delivered in connection herewith or the transaction related hereto.
By signing this Agreement, Borrower acknowledges reading, understanding, and agreeing to all its provisions and receipt thereof.
| Inhibitor Therapeutics, Inc. | |||
| /s/ James A. McNulty | November 9, 2026 | ||
| By: | James A. McNulty, CPA | Date | |
| Its | CFO | ||
ACKNOWLEDGEMENT
By signing below, the Lender hereby acknowledges and agrees to the
terms of this Line of Credit Agreement.
Hopkins Capital Group, LLC
| /s/ Francis E. O’Donnell, Jr. | November 9, 2026 | ||
| By: | Francis E. O’Donnell, Jr | Date | |
| Its: | Co-Manager | ||